Cystic fibrosis year in review 2024

被引：0

作者：

Alameeri, Amel ^{[1
]}

Yavuz, Burcu Capraz ^{[2
]}

Lucca, Francesca ^{[3
]}

Bambir, Ivan ^{[4
]}

Famulska, Paulina ^{[5
]}

Cohen, Renata W. F. ^{[6
]}

机构：

[1] ST Shaikh Tahnoon Med City Hosp, Dept Adult Pulm Med, Al Ain, Abudhabi, U Arab Emirates

[2] Hacettepe Univ, Fac Med, Ihsan Dogramaci Childrens Hosp, Dept Pediat Pulmonol, Ankara, Turkiye

[3] AOUI Verona, Cyst Fibrosis Ctr, Cardiothoracovasc Dept, Verona, Italy

[4] Univ Hosp Ctr Zagreb, Cyst Fibrosis Ctr Peadiatr & Adult Zagreb, Zagreb, Croatia

[5] Polanki Childrens Hosp, Dept Pediat & Cyst Fibrosis, Gdansk, Poland

[6] Inst Fernandes Figueira FIOCRUZ, Pediat Cyst Fibrosis Ctr, Dept Pediat Pulmonol, Rio De Janeiro, RJ, Brazil

来源：

JOURNAL OF CYSTIC FIBROSIS | 2025年 / 24卷 / 02期

关键词：

Cystic fibrosis; CFTR-RELATED DISORDERS; ECFS STANDARDS; MODULATOR USE; ELEXACAFTOR/TEZACAFTOR/IVACAFTOR; CHILDREN; ADULTS; IMPACT; CARE;

D O I：

10.1016/j.jcf.2025.02.012

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The year 2024 marks a pivotal moment in the field of cystic fibrosis (CF) treatment, characterised by significant advancements in clinical care and an expanding body of literature on CF transmembrane conductance regulator (CFTR) modulators. These CFTR therapies have transformed the landscape of CF management, offered systemic benefits, and established new guidelines for assessing clinical manifestations and therapies. Additionally, progress has been made in newborn screening (NBS), diagnosis, and understanding outcomes for individuals with CF-related metabolic syndrome or inconclusive diagnostic results. However, amidst these clinical milestones, disparities in global access to CFTR modulators (CFTRm) persist, threatening to exacerbate existing inequities in CF care. This review provides a focused overview of the most impactful articles from 2024, highlighting both the clinical advancements and the pressing global accessibility challenges that define this transformative era in CF research and treatment.

引用

页码：218 / 223

页数：6

共 50 条

[21] Cystic fibrosis year in review 2019: Section 1 CFTR modulators
Savant, Adrienne P.
McColley, Susanna A.
PEDIATRIC PULMONOLOGY, 2020, 55 (12) : 3236 - 3242
[22] Complications of indwelling catheters in cystic fibrosis - A 10-year review
Aitken, ML
Tonelli, MR
CHEST, 2000, 118 (06) : 1598 - 1602
[23] Cystic fibrosis papers of the year 2009
Balfour-Lynn, Ian M.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2010, 103 : S6 - S14
[24] Cystic fibrosis Papers of the year 2008
Balfour-Lynn, Ian M.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2009, 102 : S29 - S35
[25] Cystic Fibrosis Papers of the Year 2016
Doull, Iolo
PAEDIATRIC RESPIRATORY REVIEWS, 2018, 26 : 10 - 12
[26] Cystic fibrosis papers of the year 2017
Doull, Iolo
PAEDIATRIC RESPIRATORY REVIEWS, 2018, 27 : 2 - 5
[27] Cystic Fibrosis Papers of the Year 2013
Doull, Iolo
PAEDIATRIC RESPIRATORY REVIEWS, 2014, 15 : 10 - 12
[28] Cystic Fibrosis Papers of the Year 2015
Doull, Iolo
PAEDIATRIC RESPIRATORY REVIEWS, 2016, 20 : 18 - 20
[29] Cystic Fibrosis Papers of the Year 2012
Doull, Iolo
PAEDIATRIC RESPIRATORY REVIEWS, 2013, 14 : 28 - 30
[30] 2024: A Year in Review
Berney, Thierry
Bellini, Maria Irene
Benning, Louise
Bestard, Oriol
Masset, Christophe
Moeckli, Beat
Pascale, Marco Maria
Pilat, Nina
Sabatino, Mario
Schneeberger, Stefan
TRANSPLANT INTERNATIONAL, 2025, 37

← 1 2 3 4 5 →